BF
HRMY icon

BOK Financial’s Harmony Biosciences HRMY Stock Holding History

BOK Financial’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$506K Buy
13,904
+98
+0.7% +$3.09K 0.01% 557
2026
Q1 		$387K Sell
13,806
-961
-7% -$31.5K 0.01% 586
2025
Q4 		$553K Sell
14,767
-79
-0.5% -$2.6K 0.01% 527
2025
Q3 		$409K Buy
14,846
+67
+0.5% +$2.31K 0.01% 600
2025
Q2 		$467K Buy
14,779
+1,312
+10% +$42.2K 0.01% 588
2025
Q1 		$447K Sell
13,467
-1,933
-13% -$69.3K 0.01% 589
2024
Q4 		$521K Buy
15,400
+690
+5% +$23.7K 0.01% 557
2024
Q3 		$511K Buy
+14,710
New +$517K 0.01% 565

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BOK Financial's HRMY Position: Q2 2026 in Review

BOK Financial increased its Harmony Biosciences (HRMY) stake by 0.71% in Q2 2026, buying an estimated $3.09K and bringing the position to 13,904 shares worth $506K. The position accounts for 0.01% of the portfolio, ranked #557.

BOK Financial first reported a position in HRMY in Q3 2024 and has held it in 8 quarters since. The position peaked at $553K in Q4 2025. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • BOK Financial held 13,904 shares of Harmony Biosciences worth $506K as of Q2 2026.
  • BOK Financial bought 98 Harmony Biosciences shares in Q2 2026, an estimated $3.09K.
  • Harmony Biosciences made up 0.01% of BOK Financial's portfolio in Q2 2026, its #557 holding.
  • BOK Financial first reported a position in Harmony Biosciences in Q3 2024 and has held it in 8 quarters since.
  • BOK Financial's Harmony Biosciences position peaked at $553K in Q4 2025.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.